Medicine, 2022 · DOI: http://dx.doi.org/10.1097/MD.0000000000031930 · Published: November 1, 2022
Spinal cord injury (SCI) is a severe central nervous system injury that results in the permanent loss of motor, sensory, and autonomic functions below the level of injury with limited recovery. Secondary injury impairs the ability of the mitochondria to maintain homeostasis and leads to calcium overload, excitotoxicity, and oxidative stress, further exacerbating the injury. Treatment of spinal cord injury by preserving mitochondrial biological function is a promising, although still underexplored, therapeutic strategy.
Targeting mitochondrial function could provide novel therapeutic avenues for SCI.
Development of drugs that protect mitochondria may improve outcomes after SCI.
Combining multiple drugs targeting different mitochondrial response processes may increase the neuroprotective effect in future clinical trials.